Clinical Trial Update: DUAL Pathway Inhibition to Improve Endothelial Function in Peripheral Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating dual pathway inhibition to improve endothelial function in peripheral artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Snippet

Sponsor: Radboud University Medical Center | Conditions: Peripheral Artery Disease | Phase 4 | Status: COMPLETED